Home

želva Scénář Dutý roma index tumor marker Vyvolat zápal plic Klávesové zkratky

JGO :: Journal of Gynecologic Oncology
JGO :: Journal of Gynecologic Oncology

The receiver operating characteristic of risk of ovarian malignancy... | Download Scientific Diagram
The receiver operating characteristic of risk of ovarian malignancy... | Download Scientific Diagram

Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis - ScienceDirect
Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis - ScienceDirect

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile

Reference intervals of HE4 and ROMA value according to age groups | Download Table
Reference intervals of HE4 and ROMA value according to age groups | Download Table

Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma
Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma

PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar

Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis. - Document - Gale Academic OneFile

Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
Diagnostics | Free Full-Text | Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors

Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms
Frontiers | Copenhagen index (CPH-I) is more favorable than CA125, HE4, and risk of ovarian malignancy algorithm (ROMA): Nomogram prediction models with clinical-ultrasonographic feature for diagnosing ovarian neoplasms

HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

Ovarian masses: Surgery or surveillance? | MDedge ObGyn
Ovarian masses: Surgery or surveillance? | MDedge ObGyn

Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports
Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis | Scientific Reports

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer | International Journal of Cancer
Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer | International Journal of Cancer

ROMA (Risk of Ovarian Malignancy Algorithm)
ROMA (Risk of Ovarian Malignancy Algorithm)

HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis
HE4 can Help Discriminate Women with Malignant Ovarian Tumors only if CA125 Levels are Elevated - Denise da Rocha Pitta, Luis Otávio Sarian, Elisabete Aparecida Campos, Liliana Lucci De Angelo Andrade, Luis

Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... | Download Table
Diagnostic Values of HE4, CA125, RMI and ROMA using Standard and... | Download Table

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer

differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram
differences between HE4, CA125, and ROMA values and sensitivity, PPV,... | Download Scientific Diagram